The Haemostatic Profile in COVID-19 Patients

11. Salje H, Tran Kiem C, Lefrancq N, et al (2020). Estimating the burden of SARS-CoV-2 in France. Science. 369: 208–11. doi: 10.1126/science.abc3517. Search in Google Scholar

22. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 28; 395 (10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3. Search in Google Scholar

33. ABED, N. ., ZIBOUCHE, A. ., MEDJOUDJ, S. ., GOUMEIDANE, S. ., & ROUABAH, L. (2022). Biological characteristics and mortality in patients with diabetes and COVID-19. Notulae Scientia Biologicae, 14(3), 11276. https://doi.org/10.55779/nsb14311276. Search in Google Scholar

44. Wu Z, Mc Googan JM (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA; 323:1239–42. doi:10.1001/jama.2020.2648. Search in Google Scholar

55. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine; 8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Search in Google Scholar

66. Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 14238. doi: 10.1111/all.14238. Search in Google Scholar

77. Magro C, Mulvey JJ, Berlin D, et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational Research; 220:1–3. doi: 10.1016/j.trsl.2020.04.007. Search in Google Scholar

88. Tang, D Li, X Wang, Z Sun (2020). Abnormal coagulation parameters are associated with poorprognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), p. 844-847. doi: 10.1111/jth.14768. Search in Google Scholar

99. Guan WJ 1, Liang WH, Zhao Y et al (2020). China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: A Nationwide Analysis. European Respiratory Journal. doi: 10.1183/13993003.00547-2020. Search in Google Scholar

1010. Wang D, Hu B, Hu C (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323(11):1061. doi:10.1001/jama.2020.1585. Search in Google Scholar

1111. Gao Y, Li T, Han M, et al. (2020). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. Prelease from Journal of Medical Virology; 92:791–6. doi: 10.1002/jmv.25770. Search in Google Scholar

1212. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet; 395 (10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. Search in Google Scholar

1313. Guan WJ 2, Ni ZY, Hu Y, et al (2020). China medical treatment expert group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine; 382:1707–20. doi: 10.1056/NEJMoa2002032. Search in Google Scholar

1414. Luigi Palmieri, Xanthi Andrianou et al (2020). Characteristics of COVID-19 patients dying in Italy Report based on available data on March 20^th. https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf. Search in Google Scholar

1515. Levi M, J Thachil, T Iba, et J H Levy (2020). Coagulation abnormalities and thrombosis in patients with COVID-19, The Lancet Haematology., 7(6), p. e438,. doi: 10.1016/S2352-3026(20)30145-9. Search in Google Scholar

1616. Becker RC (2020). COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis. 50:54–67. https://doi.org/10.1007/s11239-020-02134-3. Search in Google Scholar

1717. Mitra S, Ling RR, Yang IX et al (2021) Severe COVID-19 and coagulopathy: a systematic review and meta-analysis. Annals of the Academy of Medicine of Singapore. 50(4):325–335. https://doi.org/10.47102/annalsacadmedsg.2020420.Search in Google Scholar

1818. Tan CW, Fan BE, Teo WZY et al (2021). Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. Thrombosis Journal. 19:14. https://doi.org/10.1186/s12959-021-00268-9. Search in Google Scholar

1919. Fan BE, Ng J, Chan SSW et al (2021). COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. Journal of Thrombosis and Thrombolysis. 51:663–674. https://doi.org/10.1007/s11239-020-02318-x. Search in Google Scholar

2020. Klok FA, Kruip MJHA, van der Meer NJM et al (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. 191:145–147. https://doi.org/10.1016/j.thromres.Search in Google Scholar

2121. Fan B E, Ramanathan K, Sum C L L et al (2022). Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study. Journal of Thrombosis and Thrombolysis. 53:646–662. https://doi.org/10.1007/s11239-021-02575-4. Search in Google Scholar